| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.011 | 0.9 |